Early valve replacement surgery for very severe asymptomatic aortic stenosis was tied to lower long-term mortality risk ...

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic ...

This marks the first dedicated transcatheter heart valve approved for high-risk patients with symptomatic severe AR.

JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...

Medtronic (NYSE:MDT) today announced data from the ALERT trial aimed at addressing health disparities in structural heart care.

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity ...

The final results of RECOVERY add support to addressing severe aortic stenosis right away rather than waiting for symptoms.

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

What is Bicuspid Aortic Valve? Bicuspid aortic valve (BAV) is a very common congenital cardiac malformation. It afflicts about 1-2% of population with a predominance in males. The aorta is the main ...

Your aortic valve is an essential barrier between your heart and your body. When it works properly, the aortic valve is a one-way valve that separates the left ventricle, the main pumping chamber of ...